Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis-Reference-Cited by-同舟云学术

Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis

Published:2023-11-24 Issue: Volume:13 Page:
ISSN:2047-2978
Container-title:Journal of Global Health
language:
Short-container-title:J Glob Health

Author:

Ismail Nabihah Farhana¹²,Rahman Ahmed Ehsanur¹³,Kulkarni Durga¹,Zhu Fuyu⁴,Wang Xin¹⁴,del Carmen Morales Graciela⁵,Srivastava Amit⁵⁶,Allen Kristen E⁵,Spinardi Julia⁵,Kyaw Moe H⁵,Nair Harish¹⁴⁷

Affiliation:

1. Centre for Global Health, University of Edinburgh, Edinburgh, United Kingdom

2. Communicable Disease Control Unit, Public Health Department, Johor State, Malaysia

3. International Centre for Diarrhoeal Diseases Research, Bangladesh

4. School of Public Health, Nanjing Medical University, Jiangsu, China

5. Pfizer, Vaccines, Emerging Markets

6. Orbital Therapeutics, United States of America

7. MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Publisher

International Society of Global Health

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference90 articles.

1. Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing.;To;Clin Infect Dis,2021

2. Reinfection in patients with COVID-19: a systematic review.;Ren;Glob Health Res Policy,2022

3. Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain.;Rodríguez-Grande;Emerg Infect Dis,2022

4. Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Cases Corroborated by Sequencing.;Massachi;Am J Trop Med Hyg,2021

5. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study.;Hansen;Lancet,2021